550 related articles for article (PubMed ID: 10657500)
1. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney.
Oellerich WF; Malik KU
J Pharmacol Exp Ther; 1993 Sep; 266(3):1321-9. PubMed ID: 8371140
[TBL] [Abstract][Full Text] [Related]
5. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Malmström RE; Balmér KC; Lundberg JM
Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
[TBL] [Abstract][Full Text] [Related]
7. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
J Pharmacol Exp Ther; 1993 Apr; 265(1):172-7. PubMed ID: 8474004
[TBL] [Abstract][Full Text] [Related]
8. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
Ekelund U; Erlinge D
Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
[TBL] [Abstract][Full Text] [Related]
9. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
[TBL] [Abstract][Full Text] [Related]
10. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
You J; Edvinsson L; Bryan RM
J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction.
Dubinion JH; Mi Z; Zhu C; Gao L; Jackson EK
Hypertension; 2006 Mar; 47(3):545-51. PubMed ID: 16365188
[TBL] [Abstract][Full Text] [Related]
13. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.
Parrado C; Díaz-Cabiale Z; García-Coronel M; Agnati LF; Coveñas R; Fuxe K; Narváez JA
Neuropharmacology; 2007 Feb; 52(2):684-92. PubMed ID: 17087983
[TBL] [Abstract][Full Text] [Related]
14. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
16. The Y1 receptor subtype mediates the cardiovascular changes evoked by NPY administered into the posterior hypothalamic nucleus of conscious rat.
Martin JR
Brain Res; 2004 Mar; 1002(1-2):11-20. PubMed ID: 14988028
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neuropeptide Y Y1 receptors by testosterone in vascular smooth muscle cells in rat testis.
Kopp J; Collin O; Villar M; Mullins D; Bergh A; Hokfelt T
Neuroendocrinology; 2008; 88(3):216-26. PubMed ID: 18535365
[TBL] [Abstract][Full Text] [Related]
18. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
[TBL] [Abstract][Full Text] [Related]
19. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.
Callanan EY; Lee EW; Tilan JU; Winaver J; Haramati A; Mulroney SE; Zukowska Z
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1811-7. PubMed ID: 17804485
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
